[Pathogenesis of tolylene diisocyanate intoxication].
Experimental and clinical investigations to evaluate immunity, lipid peroxidation (LPO), and antioxidative defense (AOD) under the action of tolylene diisocyanate at the level of MAC and 10 MAC were conducted for further studies of the agent's pathogenetic mechanisms. The experimental investigations showed the predominant activation of cellular and humoral immunities, as well as the suppression of nonspecific defence at 10 MAC, enhanced LPO, and phasic changes in AOD. Most profound immunological changes were observed in those having as long as 5 years of length of service.
Osipova
T V
TV
Litovskaia
A V
AV
Vasil'eva
T V
TV
Egorova
I V
IV
Feklina
T Iu
TIu
Vifleemskiĭ
A B
AB
D000293:Adolescent; D000328:Adult; D000818:Animals; D001991:Bronchitis / Q000139:chemically induced* / Q000276:immunology / Q000378:metabolism; D002908:Chronic Disease; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000276:immunology*; D015227:Lipid Peroxidation; D008297:Male; D008452:Maximum Allowable Concentration; D008875:Middle Aged; D009784:Occupational Diseases / Q000139:chemically induced* / Q000276:immunology / Q000378:metabolism; D016273:Occupational Exposure; D051381:Rats; D013997:Time Factors; D014051:Toluene 2,4-Diisocyanate / Q000506:poisoning* / Q000633:toxicity
D014051:Toluene 2,4-Diisocyanate